Navigation Links
instaCare Corp. Continues Turnaround, Reports 58% Revenues Increase for First Three Quarters

LOS ANGELES, Nov. 18 /PRNewswire-FirstCall/ -- instaCare Corp., (OTC Bulletin Board: ISCR), a leading distributor of life-saving prescription drugs and at-home testing diagnostics for the chronically ill, and a leading developer of patentable technologies for e-pharmacy, e-health and EMR applications, reported financial results for the third quarter period-ended September 30, 2009. Recent highlights include:

  • Revenue grew by 58% through the first three quarters in 2009 vs. the same period in 2008 as sales and orders for at-home diagnostics and medical surgical products surged
  • ISCR reports enhanced 2009 net income of $1,636,610 vs. 2008 loss of $16,775
  • Company offers cell phone EMR technologies to capitalize on Obama Administration health initiatives
  • Company announces intellectual property and patent strategies to secure its e-health and EMR technologies for Apple iPhone, Palm Pre and Verizon Windows phones

For the third quarter ended September 30, 2009 the company reported revenues of $4,491,831 vs. $3,439,271 for the same period in 2008. Through the first three quarters of 2009, instaCare reported revenues of $14,669,886 vs. $9,257,347 for the same period in 2008, a gain of 58%. The increase in revenues was due primarily to surging sales from the company's sale of at-home medical diagnostic and medical disposable products for patients with chronic diseases. The Company reported an operating profit of $161,967 during the third quarter of 2009 compared with an operating profit of $51,195 recorded during the third quarter 2008, a gain of 316%. Operating profit for the first nine months of 2009 was $1,636,610 vs. an operating loss of $16,775 for the same period in 2008. instaCare had cash, accounts, inventory and equivalents of $3,460,141 as of September 30, 2009 vs. $2,856,791 for the same period in 2008.

Keith Berman, chief financial officer of instaCare, commented, "This has been an exceptional quarter and a truly exciting nine months for instaCare, as our businesses and our profits grew, on surging sales. We were also able to clear away some of the overhang that has made our jobs difficult dating back to 2005. Finally, even with the challenges of a growing diagnostics business in a sour economy, we have managed to upgrade our e-health and EMR medical software and communications technologies and mating these technologies with the revolutionary smart cell phones manufactured by Apple, Palm, RIM and HTC. We are positioned right at the sweet spot of the Obama Administration health cost savings and efficiency initiatives. We plan to file our patent applications shortly."

Forward Looking Statements:

This release contains forward-looking statements about our business or financial condition that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions.

For further information and earnings tables, visit the company's Web Site:

    Company Contact:
    instaCare Corp.
    Keith Berman
    (805) 446-1973

SOURCE instaCare Corp.

SOURCE instaCare Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
2. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
3. WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock
4. Helix BioPharma Corp. Announces Fiscal 2009 Results
5. Cantel Medical Corp. To Hold Conference Call To Discuss Fourth Quarter and Fiscal 2009 Results
6. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
7. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
8. BioSpecifics Technologies Corp. Announces XIAFLEX(TM) CORD I Study Published in New England Journal of Medicine
9. BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference
10. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
11. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 USP ... hazardous drug preparations (e.g. pharmacists, pharmacy technicians, nurses, ... veterinary technicians). The chapter also covers all entities ... (e.g., pharmacies, hospitals, other healthcare institutions, patient treatment ... --> --> What ...
(Date:11/25/2015)... 25, 2015  Mindray Medical International ... MR ), a leading developer, manufacturer ... today announced that it will hold ... shareholders at the Company,s Hong Kong office (FLAT/RM ... Edward West Road, Mongkok KL, Hong Kong) ...
(Date:11/25/2015)... 2015 Research and Markets ( ) ... - Global Forecast to 2020" report to their ... for 37.21% of the total market share in 2014. ... region is projected to growth at the highest CAGR ... primarily to the fast growing water, industrial gas treatment, ...
Breaking Medicine Technology:
(Date:11/25/2015)... LOUIS, Missouri (PRWEB) , ... November 25, 2015 ... ... Project HEAL, will provide scholarships for people struggling with eating disorders as a ... Proceeds from the second annual event, held at Fox Run Golf Club in ...
(Date:11/25/2015)... Florida (PRWEB) , ... November 25, 2015 , ... ... LLC has announced that it has undertaken significant expansion of its current state ... The investment is part of PharmaTech’s strategy to increase its manufacturing capacity as ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bcureful—a ... (TSC), as well as raising public awareness of the disorder while helping to ... third donation of $35,000 to bolster progress at the Tuberous Sclerosis Complex Center ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion Bootie , the ... celebration of the early holiday shopping season. Starting Wednesday November 25th, Bunion Booties ... Black Friday promotional pricing is in addition to any automatic discounts applied when ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Todd S. Afferica, a ... services to many of his patients. Dr. Afferica now uses the BIOLASE WaterLase iPlus ... amount of time the doctor uses other traditional cutting tools, such as the scalpel ...
Breaking Medicine News(10 mins):